With 1.2 million diabetes sufferers Australia-wide*, understanding the disease and discovering new treatments is imperative. Current research that encompasses prevention, treatment and complications of the disease is focused on many different areas of diabetes research, including clinical type 2 diabetes and obesity research, studies of diabetes complications and the biological basis for type 1 and type 2 diabetes.

Type 1 Diabetes

Type 1 diabetes affects more than 120,000 Australians and usually occurs in childhood, and is caused by the immune system attacking cells in the pancreas that produce insulin. Apart from insulin, currently there is no other treatment for people suffering type 1 diabetes.

Research into type 1 diabetes at TRI includes:

  • Mater Research Professor Josephine Forbes and her team are investigating the connection between type 1 diabetes and dysfunctions of biological pathways involved in the addition of specific sugars to proteins which generate modified variants named "advanced glycation end products" (AGEs).These studies will help us better understand this system in humans and if it can be targeted by medicines to prevent type 1 diabetes development. Read more.
  • UQ Associate Professor Raymond Steptoe and his team are engineering human dendritic cells for tolerogenic gene therapy of type 1 diabetes. This project will test a newly-developed immunotherapeutic approach in a humanized mouse model of disease. Successful completion would accelerate the translation of this approach as a potential cure for type 1 diabetes. Read more
  • UQ Professor Ranjeny Thomas is developing a new form of immunotherapy using a small fat particle that encapsulates an ‘immune red flag’ protein from the pancreas, along with a drug to calm the immune response. Read more
  • UQ-DI Dr Emma Hamilton-Williams is working towards understanding the link between diabetes and the gut to determine the role of gut bacteria in disease progression. Read more

Type 2 Diabetes 

Mater Research-UQ Professor Mike McGuckin is using mouse models to investigate whether natural control of blood glucose can be restored in type 2 diabetes by administration of the cytokine IL-22. Read more

Diabetic Kidney Disease

Mater-UQ's Professor Josephine Forbes is also working with her team to investigate ways to prevent progression of diabetic kidney disease by targeting mitochondrial function. Read more on the TRI website and Mater Research website

*Includes type 1 and type 2 diabetes.

Related News

Key Researchers
John Prins
Jon Whitehead
Michael McGuckin
Emma Hamilton-Williams
Josephine Forbes
Ranjeny Thomas
Raymond John Steptoe
Show More ...
International Clinical Trials Day: Q and A with TRI’s Steve Turner On International Clinical Trials Day on 20 May, we honour the incredibly hardworking professionals in the clinical trials...Read more
Potent dietary fibre may help halt immune attack in people with diabetes A plant-based fibre supplement could strengthen and regulate the immune system in those with type 1 diabetes or those at risk...Read more
Tackling Type 1 diabetes from prevention to better treatments At the Translational Research Institute, a Mater Research group led by Professor Josephine Forbes is at the international forefront of...Read more
Over $5.9 million in NHMRC funding awarded to TRI-based researchers for 2019 In the latest round of NHMRC funding announced this month, TRI-based researchers from UQ, QUT and Mater-UQ have secured...Read more
Gut reaction linked to type 1 diabetes Source: UQ News, 13 August 2018 Understanding the link between diabetes and the gut could lead to the development of new therapies to delay the onset of type 1...Read more
National Diabetes Week 2018 National Diabetes Week runs from 8 July to 14 July 2018. The week focuses on creating greater awareness of better and early detection for all types of diabetes. It is...Read more
World Health Day 2016 - Diabetes On the 7th April 2016, World Health Day focuses on Diabetes this year so we're putting the spotlight on all things Diabetes at TRI. Diabetes is a complicated auto...Read more
mri-uq discovery may revolutionise diabetes treatment A Queensland-based researcher is on the verge of a significant new approach to treatment for people with Type 2 diabetes. Professor Mike McGuckin...Read more
TALENTED TRI-BASED RESEARCHERS RECOGNISED AT WOMEN IN TECHNOLOGY AWARDS The outstanding work of TRI researchers has been recognised with two winners at the 17th Annual Women in Technology (WiT)...Read more